Today's Date
Tocilizumab (TCZ) in New-onset Type 1 Diabetes
(
EXTEND
)
ITN Protocol #:
ITN058AI
Branded Name:
EXTEND
ClinicalTrials.Gov ID:
NCT02293837Treatment Protocol #:
Therapeutic Area:
Type 1 Diabetes
Current Status:
Complete
Summary:
Preserving Beta-Cell Function with Tocilizumab in New-onset Type 1 Diabetes
Clinical Operations Associate Director
Clinical Operations Manager
ITN Biologist
ITN Clinical Trial Physician
NIAID Project Manager
Rho Data Manager
Study Personnel:
